Prollenium Medical Technologies Inc.
Christy Fung is a Quality Control Associate at Prollenium Medical Technologies Inc. with a solid background in biotechnology. Experience includes serving as a Research and Development Technician at New Zeta Innovation Limited, focusing on recombinant protein drug research and various analytical techniques such as HPLC, UPLC, and molecular biology methods. Previous roles also include a Microbiology Laboratory Analyst at Bright Future Pharmaceutical Lab. Ltd., where quality control tests were performed, and a Summer Intern at The Hong Kong Institute of Biotechnology Limited, assisting in drug production and quality control. Christy holds a Master of Science degree in Biotechnology from The Hong Kong University of Science and Technology and a Bachelor of Applied Science in Biotechnology from Hong Kong Baptist University.
Prollenium Medical Technologies Inc.
Prollenium Medical Technologies Inc. is a fast-growing Canadian manufacturer and distributor of premium HA dermal filler. We are proud to address all of our client's needs through streamlined medical device innovation. Prollenium is able to ensure a continual flow of creation, unique ideas, and a steady pipeline of new and exciting products that provide safe and effective results. US FDA, Health Canada, and CE approvals, over 4 million syringes in the Revanesse product line have been sold to 80+ countries world-wide. Prollenium is the only manufacturer of Hyaluronic Acid dermal fillers in North America. Join our dedication to innovation.